Paper41367201
IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in Diabetes.
Jones EM and 13 others. Eur J Immunol, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in Diabetes. Papers, record 41367201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41367201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Interleukin-10 | Major topic |
| SARS-CoV-2 | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| COVID-19 | Major topic |
| Interleukin-13 | Major topic |
| COVID-19 Vaccines | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| Vaccination | |
| Aged | |
| Immunologic Memory |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Diabetes UK | United Kingdom | PubMed | ||
| Austrian Science Fund | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34465633 | Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. | Science | 2021 | https://conductscience.org/library/papers/34465633 | PubMed |
| 2 | 32998157 | COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. | Nature | 2020 | https://conductscience.org/library/papers/32998157 | PubMed |
| 3 | 32516066 | Diabetes mellitus as a vaccine-effect modifier: a review. | Expert Rev Vaccines | 2020 | https://conductscience.org/library/papers/32516066 | PubMed |
| 4 | 16007521 | Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/16007521 | PubMed |
| 5 | 26046523 | Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection. | PLoS One | 2015 | https://conductscience.org/library/papers/26046523 | PubMed |
| 6 | 20493574 | The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. | Diabetes Res Clin Pract | 2010 | https://conductscience.org/library/papers/20493574 | PubMed |
| 7 | 19494330 | Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. | J Immunol | 2009 | https://conductscience.org/library/papers/19494330 | PubMed |
| 8 | 36304475 | Comparing the B and T cell-mediated immune responses in patients with type 2 diabetes receiving mRNA or inactivated COVID-19 vaccines. | Front Immunol | 2022 | https://conductscience.org/library/papers/36304475 | PubMed |
| 9 | 38950078 | IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/38950078 | PubMed |
| 10 | 35181640 | IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette-Guérin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice. | J Immunol | 2022 | https://conductscience.org/library/papers/35181640 | PubMed |
| 11 | 37169862 | Accelerated waning of the humoral response to COVID-19 vaccines in obesity. | Nat Med | 2023 | https://conductscience.org/library/papers/37169862 | PubMed |
| 12 | 34027204 | Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis. | J Clin Transl Res | 2021 | https://conductscience.org/library/papers/34027204 | PubMed |
| 13 | 23173138 | Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. | Diabetes Care | 2012 | https://conductscience.org/library/papers/23173138 | PubMed |
| 14 | 33010815 | Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. | Cell | 2020 | https://conductscience.org/library/papers/33010815 | PubMed |
| 15 | 9892624 | Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. | J Exp Med | 1999 | https://conductscience.org/library/papers/9892624 | PubMed |
| 16 | 38392851 | Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract. | Pathogens | 2024 | https://conductscience.org/library/papers/38392851 | PubMed |
| 17 | 36572683 | Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19. | Nat Commun | 2022 | https://conductscience.org/library/papers/36572683 | PubMed |
| 18 | 35105982 | The T cell immune response against SARS-CoV-2. | Nat Immunol | 2022 | https://conductscience.org/library/papers/35105982 | PubMed |
| 19 | 34848490 | Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study. | Diabetes Care | 2022 | https://conductscience.org/library/papers/34848490 | PubMed |
| 20 | 18323851 | T-cell quality in memory and protection: implications for vaccine design. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18323851 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41909674 | Transcending risk factors: the implications of redefining diabetes as an immunometabolic disease for infectious disease studies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41909674 | PubMed |
| 41367201 | IL-10- and IL-13-Biased T Cell Responses to SARS-CoV-2 Vaccination in Diabetes. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/41367201 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41367201
GET https://conductscience.org/api/papers/v1/41367201/references?page=2